CD73 inhibitors
US11028120B2 · kind B2 · utility
6Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2020 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Dec 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.